Journal of Bone Oncology (Apr 2024)
#22. Investigating the TGF-β/integrin β3 signaling axis as a mediator of chemoresistance in breast cancer bone metastasis
- Kristin A. Kwakwa,
- Gregory C. Fox,
- Michael H. Ross,
- Xinming Su,
- Yalin Xu,
- Netra Navadkar,
- Gregory M. Lanza,
- Christopher A. Maher,
- Katherine N. Weilbaecher
Affiliations
- Kristin A. Kwakwa
- Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
- Gregory C. Fox
- Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
- Michael H. Ross
- Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
- Xinming Su
- Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
- Yalin Xu
- Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
- Netra Navadkar
- Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
- Gregory M. Lanza
- Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA
- Christopher A. Maher
- Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Biomedical Engineering, Washington University School of Medicine, St. Louis, MO 63110, USA; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO 63110, USA; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63110, USA
- Katherine N. Weilbaecher
- Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA
- Journal volume & issue
-
Vol. 45
p. 100560
